Interinstitutional analysis of the outcome after surgery for type A aortic dissection.
Aortic dissection
Type A aortic dissection
Volume
Journal
European journal of trauma and emergency surgery : official publication of the European Trauma Society
ISSN: 1863-9941
Titre abrégé: Eur J Trauma Emerg Surg
Pays: Germany
ID NLM: 101313350
Informations de publication
Date de publication:
Aug 2023
Aug 2023
Historique:
received:
24
11
2022
accepted:
10
02
2023
medline:
25
8
2023
pubmed:
25
2
2023
entrez:
24
2
2023
Statut:
ppublish
Résumé
To evaluate the impact of individual institutions on the outcome after surgery for Stanford type A aortic dissection (TAAD). This is an observational, multicenter, retrospective cohort study including 3902 patients who underwent surgery for TAAD at 18 university and non-university hospitals. Logistic regression showed that four hospitals had increased risk of in-hospital mortality, while two hospitals were associated with decreased risk of in-hospital mortality. Risk-adjusted in-hospital mortality rates were lower in four hospitals and higher in other four hospitals compared to the overall in-hospital mortality rate (17.7%). Participating hospitals were classified as overperforming or underperforming if their risk-adjusted in-hospital mortality rate was lower or higher than the in-hospital mortality rate of the overall series, respectively. Propensity score matching yielded 1729 pairs of patients operated at over- or underperforming hospitals. Overperforming hospitals had a significantly lower in-hospital mortality (12.8% vs. 22.2%, p < 0.0001) along with decreased rate of stroke and/or global brain ischemia (16.5% vs. 19.9%, p = 0.009) compared to underperforming hospitals. Aggregate data meta-regression of the results of participating hospitals showed that hospital volume was inversely associated with in-hospital mortality (p = 0.043). Hospitals with an annual volume of less than 15 cases had an increased risk of in-hospital mortality (adjusted OR, 1.345, 95% CI 1.126-1.607). The present findings indicate that there are significant differences between hospitals in terms of early outcome after surgery for TAAD. Low hospital volume may be a determinant of poor outcome of TAAD. ClinicalTrials.gov Identifier: NCT04831073.
Identifiants
pubmed: 36826589
doi: 10.1007/s00068-023-02248-2
pii: 10.1007/s00068-023-02248-2
pmc: PMC10449993
doi:
Substances chimiques
1,3,4,6-tetra-O-acetyl-2-azido-2-deoxyglucopyranose
80321-89-7
Banques de données
ClinicalTrials.gov
['NCT04831073']
Types de publication
Observational Study
Multicenter Study
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
1791-1801Informations de copyright
© 2023. The Author(s).
Références
J Cardiothorac Surg. 2021 Jun 10;16(1):171
pubmed: 34112230
Gen Thorac Cardiovasc Surg. 2007 Dec;55(12):483-92
pubmed: 18066639
Eur J Prev Cardiol. 2018 Jun;25(1_suppl):3-14
pubmed: 29708034
Ann Thorac Surg. 2019 Nov;108(5):1299-1306
pubmed: 31400334
Surgery. 2020 Jul;168(1):185-192
pubmed: 32507629
Eur Heart J. 2021 Dec 28;43(1):44-52
pubmed: 34468733
Eur J Cardiothorac Surg. 2017 Dec 1;52(6):1104-1110
pubmed: 28977503
Eur J Vasc Endovasc Surg. 2021 Sep;62(3):388-398
pubmed: 34384687